Literature DB >> 31621941

Novel heterozygous sequence variant in the GLI1 underlies postaxial polydactyly.

Maryam Yousaf1, Asmat Ullah2,3, Zahid Azeem4, Ayesha Isani Majeed5, Muhammad Iqbal Memon6, Tahseen Ghous7, Sulman Basit8, Wasim Ahmad2.   

Abstract

Polydactyly is one of the most common congenital abnormal phenotype of autopod, which is characterized by extra supernumerary digit in hands/feet with or without well-developed bony structure within the digits. Preaxial polydactyly (PPD), postaxial polydactyly (PAP), and meso-axial (central) polydactyly are three different isoforms of polydactyly. Genetically, at least 10 genes have been identified causing nonsyndromic polydactyly. In the present study, we have investigated a large family segregating autosomal dominant form of nonsyndromic polydactyly. Whole exome sequencing followed by Sanger sequencing revealed a novel heterozygous missense variant (NM_005269.3; c.1064C>A; p.(Thr355Asn) in the gene GLI1 segregating with the disease phenotype within the family. This study presents first familial case of autosomal dominant form of polydactyly caused by the GLI1 variant.
© 2019 Japanese Teratology Society.

Entities:  

Keywords:  zzm321990GLI1; autosomal dominant postaxial polydactyly; novel sequence variant; whole exome sequencing

Mesh:

Substances:

Year:  2019        PMID: 31621941     DOI: 10.1111/cga.12361

Source DB:  PubMed          Journal:  Congenit Anom (Kyoto)        ISSN: 0914-3505            Impact factor:   1.409


  2 in total

1.  Evaluation of Sporadic and Familial Cases with Craniofrontonasal Syndrome: A Wide Clinical Spectrum and Identification of a Novel EFNB1 Gene Mutation.

Authors:  Semra Gürsoy; Filiz Hazan; Tülay Öztürk; Rüya Çolak; Şebnem Çalkavur
Journal:  Mol Syndromol       Date:  2021-07-12

2.  Deleterious Rare Mutations of GLI1 Dysregulate Sonic Hedgehog Signaling in Human Congenital Heart Disease.

Authors:  Rui Peng; Binbin Li; Shuxia Chen; Zhiwen Shi; Liwei Yu; Yunqian Gao; Xueyan Yang; Lei Lu; Hongyan Wang
Journal:  Front Cardiovasc Med       Date:  2022-04-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.